BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25254936)

  • 1. Clinical outcomes of cT1 micropapillary bladder cancer.
    Willis DL; Fernandez MI; Dickstein RJ; Parikh S; Shah JB; Pisters LL; Guo CC; Henderson S; Czerniak BA; Grossman HB; Dinney CP; Kamat AM
    J Urol; 2015 Apr; 193(4):1129-34. PubMed ID: 25254936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy.
    Contieri R; Tan WS; Grajales V; Hensley PJ; Martini A; Bree K; Myers A; Nogueras-Gonzalez G; Navai N; Dinney CP; Guo C; Kamat AM
    BJU Int; 2024 Jun; 133(6):733-741. PubMed ID: 38374533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic outcomes of intravesical therapy in the management of nonmuscle invasive bladder cancer with variant histology.
    Lone Z; Benidir T; Wood A; Campbell RA; Alaghehbandan R; Li J; Haber GP; Eltemamy M; Haywood SC; Weight CJ; Lee BH; Almassi N
    Urol Oncol; 2024 Mar; 42(3):71.e1-71.e7. PubMed ID: 38135626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy.
    Contieri R; Hensley PJ; Tan WS; Grajales V; Bree K; Nogueras-Gonzalez GM; Lee BH; Navai N; Dinney CP; Kamat AM
    Eur Urol Oncol; 2023 Dec; 6(6):590-596. PubMed ID: 37558542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interruptions in bladder cancer care during the COVID-19 public health emergency.
    Gore JL; Follmer K; Reynolds J; Nash M; Anderson CB; Catto JWF; Chamie K; Daneshmand S; Dickstein R; Garg T; Gilbert SM; Guzzo TJ; Kamat AM; Kates MR; Lane BR; Lotan Y; Mansour AM; Master VA; Montgomery JS; Morris DS; Nepple KG; O'Neil BB; Patel S; Pohar K; Porten SP; Riggs SB; Sankin A; Scarpato KR; Shore ND; Steinberg GD; Strope SA; Taylor JM; Comstock BA; Kessler LG; Wolff EM; Smith AB
    Urol Oncol; 2024 Apr; 42(4):116.e17-116.e21. PubMed ID: 38087711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596.
    Montorsi F; Rosiello G; Gandaglia G
    Eur Urol Oncol; 2024 Apr; 7(2):300. PubMed ID: 37838554
    [No Abstract]   [Full Text] [Related]  

  • 7. Invasive Micropapillary Urothelial Carcinoma: an Uncommon and Underreported Variant in Cystectomy Specimens.
    Prasad P; Baranwal H; Agrawal V
    Indian J Surg Oncol; 2023 Mar; 14(1):222-227. PubMed ID: 36891448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic Outcomes of cT1 and cT2 Micropapillary Variant Compared with cT1 and cT2 Conventional Urothelial Carcinoma Treated with Radical Cystectomy.
    Ginsburg KB; Schober JP; Bukavina L; Murray N; Chandra AA; Chen DYT; Greenberg RE; Viterbo R; Uzzo RG; Smaldone MC; Kutikov A; Correa AF
    Urol Pract; 2022 Sep; 9(5):396-404. PubMed ID: 37145732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596.
    Contieri R; Hensley PJ; Kamat AM
    Eur Urol Oncol; 2024 Apr; 7(2):301. PubMed ID: 37806840
    [No Abstract]   [Full Text] [Related]  

  • 10. Bladder cancer in the elderly.
    Shariat SF; Milowsky M; Droller MJ
    Urol Oncol; 2009; 27(6):653-67. PubMed ID: 19879476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does radical cystectomy have a better prognosis than bladder conservative treatment in the real world?
    Nakagawa R; Izumi K; Toriumi R; Aoyama S; Kamijima T; Makino T; Naito R; Iwamoto H; Yaegashi H; Kawaguchi S; Shigehara K; Nohara T; Mizokami A
    Int J Urol; 2024 Feb; ():. PubMed ID: 38358066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of metastatic bladder pleomorphic giant cell carcinoma with pembrolizumab.
    Nezu K; Kakoi N; Tezuka F; Ota S
    IJU Case Rep; 2021 Jul; 4(4):200-203. PubMed ID: 34258526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide.
    McNally A; Rossanese M; Suárez-Bonnet A; Hardas A; Yale AD
    J Vet Intern Med; 2023; 37(4):1488-1492. PubMed ID: 37381579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer invasion along a tension-free vaginal mesh.
    Ochi A; Harada S; Fukuokaya W; Honma K; Huang T; Abe H
    IJU Case Rep; 2021 Mar; 4(2):104-107. PubMed ID: 33718818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of COVID-19 Disease on Urology Practice.
    Moussa M; Chakra MA; Papatsoris AG; Dellis A
    Surg J (N Y); 2021 Apr; 7(2):e83-e91. PubMed ID: 34104720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Panniculectomy and Cystectomy: An Approach to the Morbidly Obese Patient.
    Hugar LA; Turner RM; Gusenoff JA; Correa AF; Jacobs BL; Davies BJ
    Case Rep Urol; 2016; 2016():6980843. PubMed ID: 27195168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient experience of bladder cancer: A data linkage study.
    Shah S; Ince J; Kockelbergh R
    BJUI Compass; 2024 Mar; 5(3):382-388. PubMed ID: 38481675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of MCNA in patients with nonmuscle invasive bladder cancer at high risk for recurrence and progression after failed treatment with bacillus Calmette-Guérin.
    Morales A; Herr H; Steinberg G; Given R; Cohen Z; Amrhein J; Kamat AM
    J Urol; 2015 Apr; 193(4):1135-43. PubMed ID: 25286009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Zargar H; Espiritu PN; Fairey AS; Mertens LS; Dinney CP; Mir MC; Krabbe LM; Cookson MS; Jacobsen NE; Gandhi NM; Griffin J; Montgomery JS; Vasdev N; Yu EY; Youssef D; Xylinas E; Campain NJ; Kassouf W; Dall'Era MA; Seah JA; Ercole CE; Horenblas S; Sridhar SS; McGrath JS; Aning J; Shariat SF; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Garcia JA; Stephenson AJ; Shah JB; van Rhijn BW; Daneshmand S; Spiess PE; Black PC
    Eur Urol; 2015 Feb; 67(2):241-9. PubMed ID: 25257030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Immediate Radical Cystectomy Necessary for All Patients with Non-Muscle-Invasive Micropapillary Bladder Cancer?
    Jackson BL; Mohammed A; Mayer N; Dormer J; Griffiths TR
    Urol Int; 2016; 96(1):32-8. PubMed ID: 25924623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.